MARATTO

article · Clinical Case Reports

Undifferentiated Embryonal Sarcoma of the Liver in a 6 Years Old Male Patient: A Case Report

Abstract

Undifferentiated Embryonal Sarcoma of the Liver (UESL) is a rare, aggressive mesenchymal tumor predominantly affecting children. Its non-specific clinical presentation and variable imaging characteristics often lead to diagnostic delays and complex management. We report a 6-year-old male presenting with a 2-month history of progressive abdominal distension and pain. Initial investigations, including abdominal ultrasound and Computed Tomography (CT), revealed a large, complex intra-abdominal mass, initially raising suspicion for hydatid cyst or desmoid tumor. Despite exploratory laparotomy and initial biopsy, the diagnosis remained elusive due to equivocal immunohistochemistry. A multidisciplinary tumor board and a second pathological review from an international expert center ultimately confirmed the diagnosis of UESL. The patient received neoadjuvant chemotherapy, underwent a second extended right hepatectomy, and has currently completed 6 cycles of adjuvant chemotherapy with good progress. UESL, although rare, necessitates a high index of clinical suspicion, a thorough diagnostic workup, and collaborative multidisciplinary management to achieve favorable outcomes, particularly given its aggressive nature and potential for recurrence.

Research topics

  • Hepatocellular Carcinoma Treatment and Prognosis
  • Vascular Tumors and Angiosarcomas
  • Testicular diseases and treatments

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/ccr3.71981

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.